A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2006
12/21/2006	US20060286073 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
12/21/2006	US20060286072 A replication-defective adenoviral or adeno-associated viral vector; gene therapy for congestive heart failure; antiischemic agents
12/21/2006	US20060286071 Therapeutic pastes for medical device coating
12/21/2006	US20060286070 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	US20060286030 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells
12/21/2006	DE10061110B4 Expression der Keratingene 8 und 18 zur Therapie von Tumoren, insbesondere des Mammakarzinoms Expression of keratin genes 8 and 18 for the treatment of tumors, especially of breast cancer
12/21/2006	CA2596412A1 Anti-connexin compounds and uses thereof
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1734049A1 Tumour-associated peptides that bind to MHC-molecules
12/20/2006	EP1734048A1 Tumor-associated peptides that bind to MHC-molecules
12/20/2006	EP1733743A1 Preventives/remedies for cancer
12/20/2006	EP1733739A1 sFRP EXPRESSION POTENTIATING AGENT
12/20/2006	EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006	EP1733733A1 Regulator for adiponectin receptor expression
12/20/2006	EP1733045A1 Design and therapeutic use of adpase enhanced apyrases
12/20/2006	EP1733036A2 Cancer prognosis and/or diagnosis method
12/20/2006	EP1732947A2 Growth factor binding constructs materials and methods
12/20/2006	EP1732945A1 Methods and compositions for modulating cardiac contractility
12/20/2006	EP1732615A2 Production of peptides in plants as viral coat protein fusion
12/20/2006	EP1732614A2 Methods and compositions for treating neuropathic and neurodegenerative conditions
12/20/2006	EP1732608A2 Folate conjugates and complexes
12/20/2006	EP1732594A2 Method for the delivery of sustained release agents
12/20/2006	EP1732591A2 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
12/20/2006	EP1732383A2 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
12/20/2006	EP1660687A4 Rnai-based modification of heterochromatin
12/20/2006	EP1519745B1 Method to enhance an immune response of nucleic acid vaccination
12/20/2006	EP1472348B1 Ultraviolet light for light activated gene transduction in gene delivery
12/20/2006	EP1023453B1 Tgc method for inducting targeted somatic transgenesis
12/20/2006	EP0942983B1 Streptococcus pneumoniae antigens and vaccines
12/20/2006	EP0833660B1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/20/2006	CN1882693A Polyethyleneglycol-modified lipid compounds and uses thereof
12/20/2006	CN1882687A Method of growing myocardial cells
12/20/2006	CN1882682A Method of preparation of pharmaceutically grade plasmid DNA
12/20/2006	CN1882603A mRNA transfected antigen presenting cells
12/20/2006	CN1880458A Human source chromosome targeting vector of human beta-globin gene cluster and application therefor
12/20/2006	CN1880457A Ad6重组核酸 Ad6 recombinant nucleic acid
12/20/2006	CN1880455A Human tumor suppressor gene NECL2 and apoptosis of leukemia cells induced by its interactive protein
12/20/2006	CN1880453A Nerve differentiation induced gene Ccd1 having high expression in brain
12/20/2006	CN1880332A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1880331A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1880330A siRNA double-chain for suppressing bc1-2 gene expression
12/20/2006	CN1879891A Method for expressing human insulin for reducing blood sugar by transgenic lucid ganoderma
12/20/2006	CN1291012C Altered strain of modified vaccinia virus ankara (MVA)
12/19/2006	US7151090 Methods for enhancing graft survival by modulating heme oxygenase activity
12/19/2006	US7150970 RNA molecules (e.g., antisense, RNAi, or siRNA) specific for VEGF-C
12/19/2006	US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	CA2251169C Quaternary cytofectins
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2146747C Liver reserve cells
12/19/2006	CA2145064C Improvements in or relating to immune response modification
12/16/2006	CA2512492A1 Methods and reagents for inhibiting cell proliferation
12/14/2006	WO2006133135A2 Herpes virus-based compositions and methods of use
12/14/2006	WO2006133052A2 A cellular therapy for ocular degeneration
12/14/2006	WO2006133022A2 Compositions and methods for decreasing microrna expression for the treatment of neoplasia
12/14/2006	WO2006132950A2 Therapeutic polymers and methods of use
12/14/2006	WO2006132251A1 Prophylactic/therapeutic agent for adult t cell leukemia
12/14/2006	WO2006131925A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
12/14/2006	WO2006131562A2 Diagnostic and therapeutic target cdc2l6 gene and proteins for neurodegenerative diseases
12/14/2006	WO2006130976A1 Interfering rnas, methods for their production, and use
12/14/2006	WO2006103452A3 Improved nitroreductase enzymes
12/14/2006	WO2006084179A3 Hiv tat-cd4 hybried molecules and methods of use thereof
12/14/2006	WO2006081008A3 Nucleic acids for apoptosis of cancer cells
12/14/2006	WO2006046017A8 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060282921 Transgenic plant-derived siRNAs for suppression of influenza virus propagation in mammalian cells
12/14/2006	US20060282909 Methods and compositions for therapeutic intervention in cardiac hypertrophy
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281788 Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
12/14/2006	US20060281771 Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
12/14/2006	US20060281769 Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
12/14/2006	US20060281755 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281703 Treatment of disease using an improved regulated expression system
12/14/2006	US20060281702 Combinatorial selection of phosphorothioate aptamers for RNases
12/14/2006	US20060281701 antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Filoviridae family, and in the treatment of a viral infection. The compounds and methods relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses.
12/14/2006	US20060281700 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
12/14/2006	US20060281699 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/14/2006	US20060281698 a single-stranded antisense oligonucleotide, targeted to nucleic acid encoding lipid-free protein constituents of plasma lipoproteins, used for diagnosis and therapy of cardiovascular disorders, including myocardial infarction and atherosclerosis
12/14/2006	US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
12/14/2006	US20060281696 Decoy-oligonucleotide-inhibition of cd40-expression
12/14/2006	US20060281680 Methods and compositions for modulating vascular integrity
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281678 Novel inhibitor of angiogenesis, tumor progression, and metastasis targeting ras signalling pathway
12/14/2006	US20060281180 Vectors
12/14/2006	US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281128 Compositions and methods using lentivirus-based vectors for generating immune responses
12/14/2006	US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060281083 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
12/14/2006	US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006	US20060281073 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system
12/14/2006	US20060281070 Synthetic genetic expression cassette comprising human preproenkephalin sequences for use in treating neuropathic pain
12/14/2006	US20060280812 Compositions and methods for the treatment of muscular dystrophy
12/14/2006	US20060280798 Nanoparticles for delivery of a pharmacologically active agent
12/14/2006	US20060280796 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent

1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 870